Publication | Open Access
Objective Response Rate Among Patients With Locally Advanced or Metastatic Sarcoma Treated With Talimogene Laherparepvec in Combination With Pembrolizumab
198
Citations
28
References
2020
Year
ClinicalTrials.gov identifier: NCT03069378.
| Year | Citations | |
|---|---|---|
Page 1
Page 1